Clinical Trials in California

Showing 161-180 of 5,448 trials

RECRUITING63 miles

Objective Assessment of Intraocular Lens Tilt and Decentration

NCT07324200

Prospective, multi-center, non-interventional, open label, randomized clinical study.

Tilt and Decentration

Johnson & Johnson Surgical Vision, Inc.80 participantsStarted Mar 2026

Bakersfield, California, United States • Sioux City, Iowa, United States

COMPLETED63 miles

Comparison of Methods for Assessing Intraocular Lens Position

NCT07218419

Prospective, multi-center, non-interventional, open label, clinical study.

Tilt and Decentration

Johnson & Johnson Surgical Vision, Inc.53 participantsStarted Nov 2025

Bakersfield, California, United States • Sioux City, Iowa, United States

ACTIVE_NOT_RECRUITINGPHASE3129 miles

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

NCT05739383

CKJX839D12302 is a pivotal Phase III study designed to test the hypothesis that treatment with inclisiran sodium 300 milligram (mg) subcutaneous (s.c.) administered on Day 1, Day 90, and every 6 months thereafter in patients at high cardiovascular (CV) risk without a prior major atherosclerotic cardiovascular disease (ASCVD) event will significantly reduce the risk of 4-Point-Major Adverse Cardiovascular Events (4P-MACE) defined as a composite of CV death, non-fatal myocardial infarction (MI), non-fatal ischemic stroke, and urgent coronary revascularization, compared to placebo.

Primary Prevention of Atherosclerotic Cardiovascular Disease

Novartis Pharmaceuticals14,078 participantsStarted Mar 2023

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Fairhope, Alabama, United States +984 more locations

Objective Assessment of Intraocular Lens Tilt and Decentration

Comparison of Methods for Assessing Intraocular Lens Position

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Find Trials by Condition in California

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

An International Observational Study of Adults With Acute Infection

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV